FPI-2119 offers potential solution to multi-drug-resistant Gram-negative infections. EDMONTON, Alberta , Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader i ...

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have uncovered how a ...

Antibiotic resistance is often framed as a hospital problem, but a growing body of evidence shows that the environment plays ...

Thyme, rosemary, and lavender have long been associated with natural medicine. Today, however, these aromatic plants are ...

As "superbugs" continue to surge, the World Health Organization is now warning that one in every six bacterial infections are resistant to antibiotics. WHO also called for antibiotic medications to be ...

Targeted protein degradation presents a promising strategy to address antimicrobial resistance, focusing on innovative ...

More than 39 million people worldwide could die from antibiotic-resistant infections over the next 25 years, and another 130 million could die of related causes, according to a landmark new study that ...

The company joins a group of degrader ADC (or DAC) developers that includes Bristol Myers Squibb and Pfizer.

As antibiotic resistance continues to spread, researchers are exploring new approaches to stay ahead of the problem.

From diagnostics to CRISPR and policy reform, explore how science and society are working together to combat the rising ...

To encourage antibiotic innovation, the U.S. is considering major policy changes like the PASTEUR Act. This bipartisan bill ...

Tackling antibiotic resistance likely requires a multifaceted approach. Better and faster point-of-care testing, new treatments, and antimicrobial stewardship could hold promise for future control.